NEW YORK (GenomeWeb News) – A second Dream Team project has been created for translational research into prostate cancer with $10 million in funding over three years.

The project was announced today by Stand Up to Cancer, its scientific partner the American Association for Cancer Research, and the Prostate Cancer Foundation, and is called "Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.